Vote Scores

Home / Companies / China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. / 15 May 2024

Meeting · year to 30 June 202436 filers reporting

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.: meeting of 15 May 2024

Votes reported on Form N-PX, item by item

36 Form N-PX filers reported votes at the China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. meeting of 15 May 2024. Their records fall into 9 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

4 nominees; 96.4% of reported votes for; 6 filers withheld from or voted against at least one nominee.

399 vote records from 36 filers. 0 of the 36 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management36 filers
2

DIRECTOR ELECTIONSSecurity holder

Director elections (nominees put forward by security holders)

7 nominees; 100.0% of reported votes for; no filer withheld from or voted against at least one nominee.

364 vote records from 24 filers. 0 of the 24 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management24 filers
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

33 vote records from 7 filers. 1 of the 7 filers that marked the item either way voted against management.

85.7% for14.3% against14.3% against management7 filers75.8% for24.2% against24.2% against management652,074 reported shares
4

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

68 vote records from 36 filers. 0 of the 36 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management36 filers100.0% for0.0% against0.0% against management4,690,198 reported shares, counted once per item in this group
5

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

68 vote records from 36 filers. 0 of the 36 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management36 filers100.0% for0.0% against0.0% against management4,690,198 reported shares, counted once per item in this group
6

OTHERIssuer

OTHER: management items

Management items in this category are shown together; filers word and number them differently.

33 vote records from 7 filers. No filer marked a management recommendation, so no against-management figure is reported. 7 filers reported this item without a management mark.

0.0% for0.0% against100.0% other7 filers
7

AUDIT-RELATEDSecurity holder

Shareholder proposal: AUDIT-RELATED (A)

52 vote records from 24 filers. 0 of the 24 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management24 filers100.0% for0.0% against0.0% against management4,011,835 reported shares
8

AUDIT-RELATEDSecurity holder

Shareholder proposal: AUDIT-RELATED (B)

52 vote records from 24 filers. 0 of the 24 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management24 filers100.0% for0.0% against0.0% against management4,011,835 reported shares
9

AUDIT-RELATEDSecurity holder

Shareholder proposal: AUDIT-RELATED (C)

52 vote records from 24 filers. 0 of the 24 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management24 filers100.0% for0.0% against0.0% against management4,011,835 reported shares

How the largest families voted

Family1. Directors2. Directors3. Auditor7. Proposal8. Proposal9. Proposal
VanguardForForNo reportForForFor
BlackRock and iSharesForForNo reportForForFor
FidelityForForNo reportForForFor
DimensionalForForNo reportForForFor
State Street and SPDRForForNo reportForForFor
Franklin TempletonForForNo reportForForFor
Charles SchwabForNo reportNo reportNo reportNo reportNo report
Nuveen and TIAAForForNo reportForForFor
John Hancock and ManulifeForNo reportForNo reportNo reportNo report
Morgan Stanley, Eaton Vance and CalvertForForNo reportForForFor
J.P. MorganForNo reportForNo reportNo reportNo report
Jackson National fundsForNo reportForNo reportNo reportNo report
Northern Trust and FlexSharesForForNo reportForForFor
Lincoln FinancialForForNo reportForForFor
VoyaForForNo reportForForFor
BNY MellonForForNo reportForForFor
Pacific Life fundsForForNo reportForForFor
TransamericaForNo reportNo reportNo reportNo reportNo report
Hartford FundsForNo reportNo reportNo reportNo reportNo report
Neuberger BermanForNo reportNo reportNo reportNo reportNo report

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. meeting?

36 Form N-PX filers reported votes at the meeting of 15 May 2024. 3 proposals from security holders could be told apart in the filings. The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. with a meeting date within three days of 15 May 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.